UA
Mitochondrial

Urolithin A

CAS 1143-70-0

Overview

Research context and commercial specification.

A gut-derived metabolite of ellagitannins, present in pomegranate and other ellagitannin-rich fruits and now produced by controlled multi-step synthesis. Urolithin A is studied less as a free-radical scavenger than as an upstream regulator of mitochondrial quality control — the machinery that tags and clears damaged organelles. The result is a distinct mechanistic profile, a simple and photostable molecule, and one of the most extensively characterised actives on the mitochondrial axis.

Research direction

Incidence on the axisMitophagy & cellular quality control
PositioningThe mitophagy active
Cellular energyMitophagy

At a glance

CAS number1143-70-0
INCI nameUrolithin A
Molecular formulaC13H8O4
Molecular weight228.20 g/mol
Purity≥99.0%
AppearancePale yellow to yellow powder
GradeResearch grade / Ultra-pure
SolubilityPoorly soluble in water; soluble in DMSO and ethanol
StorageCool, dry, protected from light — 25 °C
Shelf life36 months unopened
Packaging25 kg / drum
OriginSynthetic, multi-step controlled synthesis
Analytical methodsHPLC (purity, assay) · LC-MS (identity) · Residual solvents (GC)
CertificationISO 9001 · GMP

Published references

This library is synchronized from PubMed and shows bibliographic metadata only (title, authors, journal, year, link). No abstract or full text is reproduced. Papers flagged as context-dependent are included for scientific completeness and require careful interpretation.

  • Molecules2026
    Tenuta AC, Iacopetta D, Catalano A, et al.
    Urolithin A: Biosynthesis at a Glance and Biological Properties Supported by Recent Preclinical and Clinical Evidence.
    Open in PubMed →
  • Mitochondrion2026
    Kshirsagar S, Alvir RV, Pradeepkiran JA, et al.
    Urolithin A plus EGCG enhances mitophagy associated pathways, mitochondrial dynamics, and bioenergetic function in humanized amyloid-β knock-in mice.
    Open in PubMed →
  • Metabolism2026
    Zhou R, Bian Y, Bu Y, et al.
    Aflatoxin B1-induced metabolic remodeling promotes liver injury through an H3K18la-ACSL4-ferroptosis axis attenuated by Urolithin A.
    Open in PubMed →
  • In Vivo2026
    Cho SI, Jo ER, Oh J
    Urolithin A Attenuates Noise-induced Hearing Loss and Is Associated With Increased Cochlear Mitophagy Markers.
    Open in PubMed →

Technical questions

What is urolithin A and how is it specified?
Urolithin A is manufactured under a fixed process and released against a fixed specification. Identity, purity, residual solvents, appearance and shelf life are defined for every batch, and each batch is released with a certificate of analysis.
Which analytical methods verify this active?
Purity and assay are determined by HPLC, identity by LC-MS against a reference standard, and residual solvents by gas chromatography. The full method panel appears on the specification sheet and on the certificate of analysis issued with each batch.
How should urolithin A be handled in formulation?
Urolithin A is poorly soluble in water and is normally used in oil phases or with a carrier system. Appearance and solubility data are supplied so that phase selection can be settled before the first trial batch rather than after it.

Ask about this active

Request the complete specification dossier, a sample, or formulation guidance for Creatrich Biotech actives.

Get in touch →